about
A microRNA expression signature of human solid tumors defines cancer gene targetsPancreatic cancer genomes reveal aberrations in axon guidance pathway genesInternational network of cancer genome projects.Genetic abnormalities in pancreatic cancerMicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?Toll-like receptor 9 agonist IMO cooperates with cetuximab in K-ras mutant colorectal and pancreatic cancers.Somatic mutations in exocrine pancreatic tumors: association with patient survivalDifferential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers.Intracellular autofluorescence: a biomarker for epithelial cancer stem cellsMetastatic pancreatic cancer: Is there a light at the end of the tunnel?Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markersLoss of BAP1 Expression Occurs Frequently in Intrahepatic CholangiocarcinomaTERT gene harbors multiple variants associated with pancreatic cancer susceptibilityCommon germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumorsThree new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.A combination of molecular markers and clinical features improve the classification of pancreatic cysts.Gene expression profiles of pancreatic cancer and stromal desmoplasia.Pancreatic Neuroendocrine Neoplasms: Clinical Value of Diffusion-Weighted Imaging.Family history of gastric cancer: a correlation between epidemiologic findings and clinical data.Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group.Expression profiling of microdissected pancreatic adenocarcinomas.Identification of the regulatory proteins in human pancreatic cancers treated with Trichostatin A by 2D-PAGE maps and multivariate statistical analysis.Detection of bladder cancer by semi-automated microsatellite analysis of urine sediment.Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A.Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A.Molecular characterization of composite mantle cell and follicular lymphoma.Identification of a candidate alternative promoter region of the human Bcl2L11 (Bim) geneEndocrine neoplasms of the pancreas: pathologic and genetic features.Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomasDiscovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors.Aggressive approach to acinar cell carcinoma of the pancreas: a single-institution experience and a literature review.Mutational profiling of kinases in human tumours of pancreatic origin identifies candidate cancer genes in ductal and ampulla of vater carcinomas.Abnormal modulation of cell protective systems in response to ischemic/reperfusion injury is important in the development of mouse sickle cell hepatopathy.Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis.Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: potential relevance for adenoviral gene therapyTargeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas.The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type.
P50
Q24541455-A696BDA1-D22C-4C30-91B6-15B2C863FF7FQ24595981-F0D592E5-459D-4877-ABB7-38128B99CC70Q24611474-CDD26D86-880C-4BAC-9D0E-6B177F7B4ED3Q24800194-C02ADFFE-42C0-474D-9FC8-273FB3973990Q26799779-F26363D4-D426-4014-B658-228E5BF9F3FCQ27851667-2882264B-052B-451D-B061-05DAC6868CD0Q27852155-436E4CD9-8251-442E-A740-667B1309C247Q27853176-7225F291-7B2B-4392-B510-8AB6CFD16E15Q28049473-27D6D8C5-76BD-4F27-ADC7-697B0A3D9C17Q28082919-D446C395-DEF8-4B68-B627-5D0D059A07E1Q28258774-560A09BA-E8F8-40E5-9DBF-2174A9E70211Q28384496-8D6D3D93-72D0-4776-BF19-FCCD82A758A5Q28386653-ABD9B2F8-1A2F-42A3-82B2-BF82AF7C05A1Q28397098-D9012D4E-AB4C-4865-B033-914439591E10Q29248193-BA428A34-5495-4E18-A723-A93EB111B0EFQ30479763-D0E39979-7001-4A3D-A19A-894D0575A968Q30481575-7A02C4CD-9952-4A26-86D2-034545C7C53CQ30724746-2146630F-7B8B-4E59-9BC9-9513FFE6EE9AQ31029685-DDE9C691-2346-43EC-B032-31C1948620A1Q31030832-A79D2FD2-576A-464D-95EE-43692CB8BB17Q31034983-F71AC114-0674-47C7-B2E7-75BCE2BB5935Q31038443-8941EF09-9898-4861-875D-E707A4F419A7Q31088417-38DB9497-07F7-4B55-9771-5F1AB19D8451Q31095355-5EF43517-BDB6-4CCF-BF57-A1CF223406ABQ31803204-8D0721F4-2FFA-4FB5-B509-0D021F2FAD07Q33187257-C1400DA3-2001-41FE-9DE5-F0FB6A9EEAB0Q33228827-104528B4-E30A-44A8-9C2E-0E07DCAAF5CEQ33234422-4DA55361-06C7-4FB5-A468-7AD738286138Q33343257-6F231537-342E-4B9B-B529-861D560CC2C3Q33414797-E970C7BC-8C97-4718-B59F-42998F5C6AFEQ33581027-E708EF31-80FD-4009-8620-1D6F928B9041Q33620112-F0086993-AA89-4C3E-8E4F-D6EDAFEDBB5FQ33651984-243777A0-98A6-4FE7-91E3-5D9289F96C0DQ33677750-68F5579C-8495-487B-AA59-B5F779326EB5Q33691544-80B59A05-6870-4F21-9B08-98AD0151F3F4Q33695612-611FCAE8-A6A4-4221-AA4D-4AE345F31348Q33725877-FC05D7DE-C860-4012-83DC-D81BDC43DF6CQ33753431-1FCF599F-53B0-40B5-89B8-739EC6D099A6Q33754040-0F66B3C6-FA72-414D-A9F1-617F7ED0DCB1Q33833156-A56D082F-6658-4DCE-B382-E179C3A08ACC
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Aldo Scarpa
@ast
Aldo Scarpa
@en
Aldo Scarpa
@es
Aldo Scarpa
@nl
Aldo Scarpa
@sl
type
label
Aldo Scarpa
@ast
Aldo Scarpa
@en
Aldo Scarpa
@es
Aldo Scarpa
@nl
Aldo Scarpa
@sl
prefLabel
Aldo Scarpa
@ast
Aldo Scarpa
@en
Aldo Scarpa
@es
Aldo Scarpa
@nl
Aldo Scarpa
@sl
P1153
P214
P1053
K-6832-2016
P106
P1153
57059931700
57074880500
7102664619
P21
P214
P2798
P31
P3829
P396
IT\ICCU\UDAV\048210
P496
0000-0003-1678-739X
P569
1956-01-01T00:00:00Z
P734
P735
P7859
viaf-232958533